Accessibility to Medicines Under Compulsory Licenses: Anti- HIV/AIDS (Efavirenz, Kaletra) and Clopidogrel Sub-committee for Benefits and Services Development.

Slides:

Advertisements

Similar presentations

Gilead’s Tech Transfer Partnerships and IP in India

Advertisements

FINANCING ARV EXPERIENCE FROM MALAYSIA BY SHA’ARI NGADIMAN, MD, MPH, EIP, AM MINISTRY OF HEALTH MALAYSIA.

XIX International AIDS Conference July 2012 Washington DC, USA The Brazilian experience: the campaign for access to lopinavir/ritonavir and efavirenz compulsory.

Drug calculation formula

More on Generic Drugs Global Classrooms 2013 Rachel Hunkler.

Training course on Introducing pharmacovigilance into HIV/AIDS programmes Pretoria, South Africa, September 1-10,2004.

Thailand, TRIPS, and Compulsory Licensing Tanyaporn Wansom Global Health Chair, American Medical Student Association 2006 WHO Duke University.

Savings and Investment Unit Project Student Name.

1 DRUG DATABASE AND PERFORMANCE INDICATORS FOR UTILIZATION MONITORING Authors: Pongcharoensuk P 1, Angsanant M 2, Chantrakunopars P 2, Phuthong P 1, Kongsawat.

Pricing and the Pharmaceutical Industry What’s Realistic? What’s Smart? What’s Right?

TRIPS and Public Health: Thailand’s Compulsory Licenses over Patented Drugs for Chronic Diseases December 2, 2013 By Sakda Thanitcul.

The Medicines Patent Pool Ellen ‘t Hoen UNITAID Consultative Forum Geneva, 4-5 October 2011.

Measuring Adherence to Chronic Disease Treatment Using Dispensing Data: An Example from Thailand Sauwakon Ratanawijitrasin, PhD Sanita Hirunrassamee, PhD.

Getting the best treatment to the most people possible Enabling policies: threats & opportunities MSF Access Campaign.

The introduction of compulsory licenses for essential medicines in Thailand Sripen Tantivess International Health Policy Program, Ministry of Public Health,

Washington D.C., USA, July 2012www.aids2012.org Patent Oppositions in Argentina International AIDS Conference July 2012 M. Lorena Di Giano.

Nov 2004Access to Paediatric ARV formulations ENSURING SECURE and RELIABLE SUPPLY and DISTRIBUTION SYSTEMS in DEVELOPING COUNTRIES, in the CONTEXT OF HIV/AIDS.

Universal Access: To what extent current mechanisms are appropriate and sustainable to maintain free of charge treatment? Compulsory Licensing in Brazil.

Silagra 100 Kaufen Cheap Without Prescription silagra tabletten cipla silagra silagra tabs silagra 100 buy silagra vrouwen silagra buy online caverta vs.

Access to ARVs in Brazil: challenges for civil society XVII International Aids Conference Satellite Meeting on Access to Medicines and Intellectual Property.

Access to AIDS Treatment and Intellectual Property Rights’ Protection in Thailand Jiraporn Limpananont, Associate Professor Dr. at Social Pharmacy Research.

Access to Generic Medicines The Use of Compulsory Licensing

Presentation transcript:

Accessibility to Medicines Under Compulsory Licenses: Anti- HIV/AIDS (Efavirenz, Kaletra) and Clopidogrel Sub-committee for Benefits and Services Development Meeting on February 14, 2008

Stock Management of Anti- HIV/AIDS Medicines EFAVIRENZ 600 mg. Purchasing orders –First batch: 66,000 bottles (stock run out) –Second batch: 100,000 bottles (placed under the VMI system since October 2007) Monitoring on the use of Efavirenz is shown in the Table. LOPINAVIR mg RITONAVIR 33.3 mg Kaletra ® is currently prescribed. (571 bottles still in the stock) On January 28, 2008, there were 957 patients (588 adults, 369 children) using this antiviral medicine. 4,000 bottles of Indian generic arrived in stock on February 12, Monitoring on the use of Lopinavir/Ritonavir is shown in the Table.

Clopidogrel 75 mg. (tab) Already registered by GPO The registered generic drug is produced by Cadila Healthcare, an India company. Purchasing order of the first batch for 2 million tablets has been placed and is currently under the transportation process to Thailand.